https://capital.com/it-it/markets/shares/puma-biotechnology-inc-prezzo-azione-1
Puma Biotechnology, Inc. (PBYI) - Prezzo e Grafico | Fai Trading Ora | Capital.com
Ottieni Puma Biotechnology, Inc. (PBYI) valore azionario in tempo reale, investimenti, rating e informazioni sui mercati finanziari da Capital. Piattaforme...
puma biotechnology
https://www.biospace.com/puma-biotechnology-releases-updated-corporate-presentation-jan-09-2023
Puma Biotechnology Releases Updated Corporate Presentation - Jan 09, 2023 - BioSpace
Jan 10, 2023 - Puma Biotechnology, Inc., a biopharmaceutical company, provided an update to the corporate presentation that its Chief Executive Officer and President, Alan H....
jan 09 2023puma biotechnologycorporate presentationreleasesupdated
https://www.biospace.com/puma-biotechnology-reports-third-quarter-2023-financial-results
Puma Biotechnology Reports Third Quarter 2023 Financial Results - BioSpace
Nov 2, 2023 - Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced financial results for the third quarter ended September 30, 2023.
puma biotechnologythird quarter2023 financialreportsresults
https://www.biospace.com/press-releases/puma-biotechnology-to-present-at-barclays-27th-annual-global-healthcare-conference
Puma Biotechnology to Present at Barclays 27th Annual Global Healthcare Conference - BioSpace
puma biotechnology
https://www.macrotrends.net/stocks/charts/PBYI/puma-biotechnology/debt-equity-ratio
Puma Biotechnology Debt to Equity Ratio 2012-2025 | PBYI | MacroTrends
Current and historical debt to equity ratio values for Puma Biotechnology (PBYI) over the last 10 years. The debt/equity ratio can be defined as a measure of a...
debt to equity ratiopuma biotechnology20122025macrotrends
https://www.biospace.com/press-releases/puma-biotechnology-to-present-at-barclays-annual-global-healthcare-conference
Puma Biotechnology to Present at Barclays Annual Global Healthcare Conference - BioSpace
puma biotechnologyglobal healthcarepresent
https://www.benzinga.com/quote/PBYI/news
Latest Puma Biotechnology Stock News | NASDAQ:PBYI | Benzinga
Get the latest news on Puma Biotechnology stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on PBYI performance
puma biotechnologystock newslatestnasdaqbenzinga
https://stockhouse.com/companies/quote?symbol=pbyi
Puma Biotechnology Inc (NDAQ:PBYI) Stock Price Today, News, Quote & History | Stockhouse
Get today's stock prices, news and investor discussion about Puma Biotechnology Inc (NDAQ:PBYI). Research PBYI stock prices, stock quotes, stock trends and...
puma biotechnologystock price
https://www.fool.com/investing/2017/05/22/why-puma-biotechnology-applied-optoelectronics-and.aspx
Why Puma Biotechnology, Applied Optoelectronics, and Ferroglobe Jumped Today | The Motley Fool
May 22, 2017 - These stocks helped lead the market higher. Find out why.
puma biotechnologyapplied optoelectronics
https://www.businesswire.com/news/home/20240502171454/en/Puma-Biotechnology-Reports-First-Quarter-Financial-Results
Puma Biotechnology Reports First Quarter Financial Results
Puma Biotechnology will report its financial results for 1Q-2024 after the close and host a conference call at 1:30 p.m. PT on May 2.
puma biotechnologyfirst quarterreportsfinancialresults
https://finviz.com/quote?t=PBYI&ty=tr&ta=1&p=d
PBYI - Puma Biotechnology Inc Website Traffic and Mobile Apps Usage
PBYI - Puma Biotechnology Inc - Stock screener for investors and traders, financial visualizations.
puma biotechnologywebsite trafficmobile appsincusage
https://www.macrotrends.net/stocks/charts/PBYI/puma-biotechnology/operating-margin
Puma Biotechnology Operating Margin 2012-2025 | PBYI | MacroTrends
Current and historical operating margin for Puma Biotechnology (PBYI) over the last 10 years. The current operating profit margin for Puma Biotechnology as of...
puma biotechnologyoperating margin20122025macrotrends
https://www.biospace.com/puma-biotechnology-reports-second-quarter-2023-financial-results
Puma Biotechnology Reports Second Quarter 2023 Financial Results - BioSpace
Aug 4, 2023 - Puma Biotechnology, Inc., a biopharmaceutical company, announced financial results for the second quarter ended June 30, 2023.
puma biotechnologysecond quarter2023 financialreportsresults
https://www.barchart.com/stocks/quotes/PBYI/competitors?quoteSectors=-MEBI
PBYI Competitors for Puma Biotechnology Stock - Barchart.com
Competitors for Puma Biotechnology (PBYI): view how companies in the same sector perform against each other.
puma biotechnologycompetitorsstockbarchart
https://www.fool.com/investing/general/2017/05/05/why-puma-biotechnology-shares-are-crashing-182-tod.aspx
Why Puma Biotechnology Shares Are Crashing 18.2% Today | The Motley Fool
May 5, 2017 - The departure of a key executive ahead of an important FDA advisory committee meeting is raising questions.
puma biotechnology
https://www.insidermonkey.com/blog/puma-biotechnology-inc-nasdaqpbyi-q2-2024-earnings-call-transcript-1329619/
Puma Biotechnology, Inc. (NASDAQ:PBYI) Q2 2024 Earnings Call Transcript - Insider Monkey
Operator: Good afternoon. My name is Diego and I will be your conference call operator today. [Operator Instructions] As a reminder, this conference call is...
earnings call transcriptpuma biotechnologyq2 2024
https://www.barchart.com/stocks/quotes/PBYI/cheat-sheet
PBYI Trader's Cheat Sheet for Puma Biotechnology Stock - Barchart.com
Support Resistance, Pivot Points for Puma Biotechnology with Key Turning Points and Technical Indicators.
cheat sheetpuma biotechnologytrader
https://investingnews.com/daily/life-science-investing/biotech-investing/puma-biotechnology-receives-positive-chmp-opinion-recommending-approval-of-nerlynx/
Puma Biotechnology Receives Positive CHMP Opinion Recommending Approval of NERLYNX | INN
Jan 4, 2026 - Puma Biotechnology (Nasdaq:PBYI) announced that on June 28, 2018 the Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion...
puma biotechnologyreceivespositivechmp
https://www.financialcontent.com/article/publisher/Puma%20Biotechnology%2C%20Inc.
Articles from Puma Biotechnology, Inc. | FinancialContent
View all of the latest articles from Puma Biotechnology, Inc.
puma biotechnologyarticlesinc
https://www.macrotrends.net/stocks/charts/PBYI/puma-biotechnology/total-liabilities
Puma Biotechnology Total Liabilities 2012-2025 | PBYI | MacroTrends
Puma Biotechnology total liabilities from 2012 to 2025. Total liabilities can be defined as the total value of all possible claims against the corporation.
puma biotechnologytotal liabilities20122025macrotrends
https://www.barchart.com/stocks/quotes/PBYI/competitors?quoteSectors=-283E
PBYI Competitors for Puma Biotechnology Stock - Barchart.com
Competitors for Puma Biotechnology (PBYI): view how companies in the same sector perform against each other.
puma biotechnologycompetitorsstockbarchart
https://www.biospace.com/puma-biotechnology-to-present-at-cowen-and-company-healthcare-conference
Puma Biotechnology to Present at Cowen and Company Healthcare Conference - BioSpace
cowen and companypuma biotechnologypresent
https://www.biospace.com/press-releases/puma-biotechnology-reports-inducement-awards-under-nasdaq-listing-rule-5635c4-february-5-2025
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - February 5,...
https://www.biospace.com/press-releases/puma-biotechnology-to-host-conference-call-to-discuss-fourth-quarter-and-full-year-2024-financial-results
Puma Biotechnology to Host Conference Call to Discuss Fourth Quarter and Full Year 2024 Financial...
https://www.biospace.com/puma-biotechnology-announces-phase-ii-clinical-trial-design-for-alisertib-in-her2-negative-hormone-receptor-positive-metastatic-breast-cancer
Puma Biotechnology Announces Phase II Clinical Trial Design for Alisertib in HER2-Negative, Hormone...
Dec 11, 2023 - Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company (the Company), announced the design of the Phase II trial of alisertib for the treatment...
phase ii clinical trial
https://www.biospace.com/puma-biotechnology-reports-inducement-awards-under-nasdaq-listing-rule-5635c4-july-02-2024
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - July 02, 2024 -...
https://www.fool.com/investing/2019/06/05/heres-why-puma-biotechnology-shares-tumbled-539-in.aspx
Here's Why Puma Biotechnology Shares Tumbled 53.9% in May | The Motley Fool
Jun 5, 2019 - The most significant potential concern for the company's lone drug product arose.
https://www.biospace.com/puma-biotechnology-announces-fda-clearance-of-ind-for-alisertib-in-small-cell-lung-cancer
Puma Biotechnology Announces FDA Clearance of IND for Alisertib in Small Cell Lung Cancer - BioSpace
Aug 8, 2023 - Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, has been notified by the U.S. Food and Drug Administration (FDA) that its Investigational...
https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-pbyi/puma-biotechnology/news/further-weakness-as-puma-biotechnology-nasdaqpbyi-drops-11-t
Further weakness as Puma Biotechnology (NASDAQ:PBYI) drops 11% this week, taking five-year losses...
Puma Biotechnology, Inc. ( NASDAQ:PBYI ) shareholders should be happy to see the share price up 13% in the last month...